DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Tirofiban

Tirofiban

  • Safety of Tirofiban for Patients with Acute Ischemic Stroke in Routine Clinical Practice

    Safety of Tirofiban for Patients with Acute Ischemic Stroke in Routine Clinical Practice

  • Summary of the Product Characteristics

    Summary of the Product Characteristics

  • The Role of Low-Molecular-Weight Heparin in the Management of Acute Coronary Syndromes Marc Cohen, MD, FACC Newark, New Jersey

    The Role of Low-Molecular-Weight Heparin in the Management of Acute Coronary Syndromes Marc Cohen, MD, FACC Newark, New Jersey

  • GP Iib/Iiia Adult Cardiology Treatment Dosing and Monitoring Guidelines

    GP Iib/Iiia Adult Cardiology Treatment Dosing and Monitoring Guidelines

  • Summary of the Product Characteristics

    Summary of the Product Characteristics

  • Product Monograph

    Product Monograph

  • Intravenous Tirofiban Therapy for Patients with Capsular Warning Syndrome

    Intravenous Tirofiban Therapy for Patients with Capsular Warning Syndrome

  • GUIDELINE for ANTITHROMBOTIC REVERSAL Table 1

    GUIDELINE for ANTITHROMBOTIC REVERSAL Table 1

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • Aggrastat (Tirofiban Hydrochloride Injection Premixed)

    Aggrastat (Tirofiban Hydrochloride Injection Premixed)

  • Neuraxial Access Or Peripheral Nerve Procedures)

    Neuraxial Access Or Peripheral Nerve Procedures)

  • Rescue Treatment with Intra-Arterial Tirofiban Infusion and Emergent Carotid Stenting

    Rescue Treatment with Intra-Arterial Tirofiban Infusion and Emergent Carotid Stenting

  • Glycoprotein (GP) Iib/Iiia Receptor Inhibitors for Use in Acute Coronary Syndromes (ACS) & Percutaneous Coronary Intervention (PCI)

    Glycoprotein (GP) Iib/Iiia Receptor Inhibitors for Use in Acute Coronary Syndromes (ACS) & Percutaneous Coronary Intervention (PCI)

  • Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01

    Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01

  • Platelet Glycoprotein Iib/Iiia Inhibitors in Acute Ischemic Stroke

    Platelet Glycoprotein Iib/Iiia Inhibitors in Acute Ischemic Stroke

  • ANTICOAGULATION GUIDELINES for NEURAXIAL PROCEDURES Guidelines to Minimize Risk Spinal Hematoma with Neuraxial Procedures **

    ANTICOAGULATION GUIDELINES for NEURAXIAL PROCEDURES Guidelines to Minimize Risk Spinal Hematoma with Neuraxial Procedures **

  • Bivalirudin Vs Heparin with Or Without Tirofiban During

    Bivalirudin Vs Heparin with Or Without Tirofiban During

  • Tirofiban Injection

    Tirofiban Injection

Top View
  • Aspirin, but Not Tirofiban Displays Protective Effects in Endotoxin Induced Lung Injury
  • Bericht ATC-Code B01: Antithrombotische Mittel
  • Clinical Efficacy and Safety of Tirofiban Combined with Conventional Dual
  • 140-239.9 Organ Failure
  • Free PDF Download
  • Xigris, INN-Drotrecogin Alfa (Activated)
  • A Potential Radiopharmaceutical for Detection of Deep Venous Thrombosis
  • On-Pump Surgery for Acute Aortic
  • Management of Antithrombotic Agents in Patients Undergoing Flexible Bronchoscopy
  • Tirofiban 50 Micrograms/Ml Solution for Infusion
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • Nursing In-Service Using Concentrated Bolus Vial (250 Mcg/Ml)
  • Anticoagulation Reversal
  • Effectiveness of Tirofiban, Eptifibatide, and Abciximab in Minimizing
  • Benefit of Standard Versus Low-Dose Tirofiban for Percutaneous Coronary Intervention in Very Elderly Patients with High-Risk Acute Coronary Syndrome
  • Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
  • Release of Soluble CD40L from Platelets Is Regulated by Glycoprotein Iib/Iiia and Actin Polymerization Mark I
  • 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27


© 2024 Docslib.org    Feedback